Navigation Links
| HOME >> MEDICINE >> TECHNOLOGY |
Lakewood-Amedex Inc. to Develop Broad Spectrum Influenza Drug to Include H1N1 and H5N1 Type A Strains
Date:8/27/2009
eudomonas and others, and patents covering certain proprietary products targeting pandemic viral infections including Epstein Barr Virus (EBV), human and avian influenza, Hepatitis B and C and other clinical indications. The Company anticipates initiating human clinical trials for topical use of its Nu-3 NuBiotics compound in the near future for indications including diabetic ulcers and other topical infections. Future studies will involve the use of Nu-2 to treat broad spectrum antibiotic-resistant bacterial pulmonary and systemic infections. The company is currently conducting a human IRB clinical study to improve treatment of nasopharyngeal carcinoma in Changsha, China. Lakewood-Amedex is headquartered in Sarasota, FL.
'/>"/>
| SOURCE Lakewood-Amedex Inc. Copyright©2009 PR Newswire. All rights reserved |
Related medicine technology :
1. Karolinska Development Portfolio Company Launches GMP Facility for Particulate Manufacturing
2. New Consortium to Develop Drugs for Neglected Tropical Diseases
3. OncoGenex Expands Clinical Development of OGX-427 with a Phase 1 Clinical Trial in Bladder Cancer
4. Juvenile Diabetes Research Foundation, The Genomics Institute of the Novartis Research Foundation Announce Innovative Diabetes Drug Discovery and Development Partnership
5. Debiopharm Group and Mercury Therapeutics, Inc. Sign an Exclusive License Agreement for the Development and Commercialisation of Debio 0930
6. Access Pharmaceuticals Provides Update on ProLindac Clinical Development Program
7. Cryo-Cell Announces Celle(SM) Research and Development Collaboration with Cryopraxis Cryobiology Ltd.
8. Tibotec Pharmaceuticals Announces Agreement to Develop and Commercialize a New Fixed-Dose Combination of TMC278 and Truvada(R) With Gilead Sciences
9. Current Status of the Development Programs of New Indications and Formulations for Aricept(R) for Enhancing Patient Value
10. Transave Receives $2.2 Million Cystic Fibrosis Foundation Award for Development of ARIKACE(TM)
11. ADHD Genes Found; Known to Play Roles in Neurodevelopment
Post Your Comments:
(Date:5/19/2013)... 20, 2013 Whole-cell pertussis vaccines were more effective ... a large recent outbreak, according to a new Kaiser ... vaccines, also called DTwP, were available from the 1940s ... ultimately led to the development of acellular pertussis vaccines, ... the United States had switched ...
(Date:5/18/2013)... Fla. , May 18, 2013 Although ... and are considered the most sensitive method for detecting ... effective in preventing cancer cases 3 . EndoChoice ® ... new Fuse™ system significantly improves the accuracy of this ... by colonoscopists. EndoChoice will be discussing these clinical trial ...
(Date:5/18/2013)... 2013 Faruqi & Faruqi, LLP, a ... securities fraud at AVEO Pharmaceuticals, Inc. ("AVEO" or ... http://photos.prnewswire.com/prnh/20120119/MM38856LOGO ) The investigation focuses ... federal securities laws by issuing materially false and/or ... trials for Tivopath (tivozanib) (titled "TIVO-1"). Specifically, the ...
Breaking Medicine Technology:Study Shows Whole-Cell Vaccine was More Effective than Acellular Vaccine During California Pertussis Outbreak 2Study Shows Whole-Cell Vaccine was More Effective than Acellular Vaccine During California Pertussis Outbreak 3Study Shows Whole-Cell Vaccine was More Effective than Acellular Vaccine During California Pertussis Outbreak 4New Study Shows Full Spectrum Endoscopy Procedure Reduces The 'Miss Rate' of Adenomas During Colonoscopy 2New Study Shows Full Spectrum Endoscopy Procedure Reduces The 'Miss Rate' of Adenomas During Colonoscopy 3Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In AVEO Pharmaceuticals, Inc. To Contact The Firm 2[0] Study Shows Whole-Cell Vaccine was More Effective than Acellular Vaccine During California Pertussis Outbreak[0] New Study Shows Full Spectrum Endoscopy Procedure Reduces The 'Miss Rate' of Adenomas During Colonoscopy[0] Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In AVEO Pharmaceuticals, Inc. To Contact The Firm
... , , THE WOODLANDS, Texas , Jan. 25 ... Jan. 24 New York Times article, " Radiation ... wants to ensure that cancer patients and the general public understand that ... and that cancer patients fighting their disease with help from the US Oncology ...
... Calif. , Jan. 25 Telik, Inc. (Nasdaq: ... 1 clinical study to evaluate ezatiostat hydrochloride (TELINTRA, TLK199) tablets ... (MDS). , This Phase 1 trial is an open label, ... in patients with non-deletion (5q-) low to intermediate-1 risk MDS. ...
Cached Medicine Technology:Benefits from Radiation Therapy Outweigh Risks for Cancer Patients 2Benefits from Radiation Therapy Outweigh Risks for Cancer Patients 3Telik Announces Initiation of Phase 1 Clinical Study of Ezatiostat Hydrochloride (TELINTRA(R), TLK199) Tablets in Combination With Lenalidomide (Revlimid(R)) in Patients With Myelodysplastic Syndrome (MDS) 2Telik Announces Initiation of Phase 1 Clinical Study of Ezatiostat Hydrochloride (TELINTRA(R), TLK199) Tablets in Combination With Lenalidomide (Revlimid(R)) in Patients With Myelodysplastic Syndrome (MDS) 3(Date:5/20/2013)... MONDAY, May 20 (HealthDay News) -- A child whose ... relatively higher risk for developing a respiratory infection before ... Researchers looked at data involving nearly 1,300 pairs of ... began study participation while in their first trimester of ... About 6 percent of the mothers lived within 100 ...
(Date:5/20/2013)... In celebration of National Women’s Health Week and ... The Feinstein Institute for Medical Research and ... in Science and Medicine (AWSM) , hosted its second ... business and community leaders from the region attended the ... science. , “Women face unique barriers to success ...
(Date:5/20/2013)... emergency departments play a growing role in the U.S. ... hospital admissions and serving increasingly as an advanced diagnostic ... RAND Corporation study. , While often targeted as the ... remain an important safety net for Americans who cannot ... slowing the growth of health care costs, according to ...
(Date:5/20/2013)... ANN ARBOR, Mich. As high schoolers prepare for ... a "study drug" -- a prescription stimulant or amphetamine ... University of Michigan poll shows only one in 100 ... teen has used a study drug., Study drugs refer ... attention deficit hyperactivity disorder (ADHD); commonly prescribed medicines in ...
(Date:5/20/2013)... 2013) Wolters Kluwer Health is ... Wilkins (LWW) published journals won 13 ASHPE awards ... member articles and publications for editorial, design, print ... honor to be recognized year after year for ... the industry with quality, depth, and impact," said ...
Breaking Medicine News(10 mins):Health News:Living Near Major Roadways in Pregnancy Tied to Respiratory Woes in Children 2Health News:North Shore-LIJ's Feinstein Institute Celebrates Women in Science During National Women’s Health Week 2Health News:North Shore-LIJ's Feinstein Institute Celebrates Women in Science During National Women’s Health Week 3Health News:Hospital emergency departments gaining in importance, study finds 2Health News:Hospital emergency departments gaining in importance, study finds 3Health News:1 in 10 teens using 'study drugs,' but parents aren't paying attention 2Health News:Wolters Kluwer Health receives 13 awards from the ASHPE 2[0] Living Near Major Roadways in Pregnancy Tied to Respiratory Woes in Children[0] North Shore-LIJ's Feinstein Institute Celebrates Women in Science During National Women’s Health Week[0] Hospital emergency departments gaining in importance, study finds[0] 1 in 10 teens using 'study drugs,' but parents aren't paying attention[0] Wolters Kluwer Health receives 13 awards from the ASHPE
... 1st, 2008 Philadelphia, PA, MORRISVILLE, Pa., June ... Chemical Dependency (ICPCD) has released its final,agenda and ... the,October 29th meeting, to be held at the ... the International Association for Pain and Chemical,Dependency., ...
... Midwest, but also in West Virginia, WASHINGTON, June ... flooding in already saturated areas of the,central United States. ... to six states in the devastated areas. Floods are ... of human hardship and,economic loss., Relief efforts are ...
... By disrupting the potassium channel of the malaria parasite, ... new malaria parasites from forming in mosquitoes and has ... tests. , By genetically altering the malaria parasite ... scientists at the University of Copenha-gen and John Hopkins ...
... superstar,Sara Evans, was presented with the national Crystal Cross ... for her work with the organization.,Evans, who has been ... 2005 was honored for the talent, time and passion ... in need. She is an award-winning singer,whose achievements include ...
... 9 Nordic Naturals, Inc., and,J.R. Carlson Laboratories, ... to dismiss the patent infringement suit entitled Nordic,Naturals, ... Inc.,filed by Nordic Naturals on May 2, 2007 ... of California. Under the terms of the stipulated,dismissal, ...
... Control Repair, Inc.,(ICR), headquartered in Warren, Michigan, received ... superior delivery of MRO Asset Management and,industrial repair ... management solutions and selling refurbished,industrial equipment to customers ... at the annual Honda of America Manufacturing,MRO Supplier ...
Cached Medicine News:Health News:8th International Conference on Pain and Chemical Dependency 2Health News:American Red Cross Responds to Floods and Tornadoes in Central United States 2Health News:American Red Cross Responds to Floods and Tornadoes in Central United States 3Health News:Researchers block transmission of malaria in animal tests 2Health News:Researchers block transmission of malaria in animal tests 3Health News:Country Music Superstar, Sara Evans, Receives Red Cross National Award 2Health News:Country Music Superstar, Sara Evans, Receives Red Cross National Award 3Health News:Country Music Superstar, Sara Evans, Receives Red Cross National Award 4Health News:Industrial Control Repair Named Honda of America Manufacturing's '2007 Supplier of the Year' 28th International Conference on Pain and Chemical DependencyAmerican Red Cross Responds to Floods and Tornadoes in Central United StatesResearchers block transmission of malaria in animal testsCountry Music Superstar, Sara Evans, Receives Red Cross National AwardNordic Naturals, Carlson Laboratories and Metagenics Announce Dismissal of Patent Infringement and Unfair Competition SuitIndustrial Control Repair Named Honda of America Manufacturing's '2007 Supplier of the Year'
Streck-Detergent IIIA is a balanced electrolyte solution for use as a rinsing and hemoglobin blanking diluent. It is manufactured specifically for use on the Abbott CELL-DYN® 1700 and 1800. The s...
... 12 Plus is a hematology control for ... Assay values are provided for the five-part ... three-part differential on the CELL-DYN 1600 and ... closed-vial stability is 75 days. Para 12 ...
... Release Technology essentially eliminates premature deployment ... anatomically designed tapered stent for better ... Rapid Exchange catheter with 6 Fr ... tip,, Radiopaque marker on catheter clearly ...
... 5-part differential control that controls all parameters, ... LH 750/LH 755, MAXM and HmX instruments. ... values for all three levels. White blood ... are within clinically significant ranges. This unique ...
Medicine Products:| Copyright © 2003-2012 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |